Increased selenium levels associated with reduced risk of colorectal cancer
the ONA take:
Increased levels of selenium, a mineral found in soil and some foods that is key to metabolism function, have been associated with a lower risk of colorectal cancer.
Research conducted by investigators based at Newcastle University, UK, the International Agency for research on Cancer (IARC-WHO), and the Royal College of Surgeons in Ireland, determined that Europeans average 80 micrograms of selenium, well below the 110-170 range seen in North America.
These lower selenium averages are probably due to a lower selenium soil content in Europe. (Current recommended dietary allowance [RDA] of selenium for adults is at least 55 micrograms per day, with a safe upper limit of 400 micrograms per day.)
The team examined selenium levels in the blood as well as selenoprotein O P levels, and they determined that a higher selenium level correlates to a lower colorectal cancer risk, with a greater correlation for women.
Although they acknowledge the need for additional study, they feel that a dietary supplement containing selenium could be beneficial for populations in which naturally occurring selenium levels are insufficient.
Increased levels of selenium have been associated with a lower risk of colorectal cancer.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|